EX-99 3 f6q2-ex991.htm EXHIBIT 99.1 PRESS RELEASE 8-K Exhibit 99.1
Exhibit 99.1
 
 

 
 
 

Contact:   Neil Lefort
Vice President, Investor Relations
(630) 527-4344
 

MOLEX REPORTS RECORD REVENUE AND ORDERS
FOR 2006 FISCAL SECOND QUARTER AND

RAISES GUIDANCE FOR FULL YEAR

 

Lisle, IL, USA – January 19, 2006 -- Molex Incorporated (NASDAQ: MOLX and MOLXA), a global electronic components company, today reported record revenue and orders for its second fiscal quarter ended December 31, 2005.  In addition, the Company raised guidance for its fiscal year ending June 30, 2006.  


Second Quarter Results


Revenue for the quarter ended December 31, 2005, was a record $697.3 million, an increase of 7.0% over the same period last fiscal year.  Revenue in local currencies rose 8.5%, as currency translation lowered net revenue by approximately $9.9 million, compared with last year’s second quarter.  Revenue for the December quarter increased 5.7% sequentially from the quarter ended September 30, 2005.

 

Net income for the December quarter was $58.5 million, or $0.31 per share, compared with $52.2 million, or $0.27 per share in the prior year quarter.  Included in the current quarter results was a restructuring charge of $6.5 million ($5.0 million after-tax or approximately $0.03 per share), relating to a previously announced restructuring program.


Revenue in the mobile phone market was very strong and increased 20% over last year’s second quarter, and 10% sequentially.  Revenue in the consumer market was also strong, increasing 12% over last year, and 11% sequentially.  Revenue in the automotive market increased 13% over last year, and was flat sequentially.  Revenue in the data products and industrial markets was flat, versus both the prior year and sequentially.


Revenue in the Far East South region, the Company’s largest region, was $235 million, an increase of 15% over last year’s second quarter in dollars, and a similar increase in local currencies.  In the Far East North region (Japan and Korea), revenue was $130 million, a decline of 3% in dollars and an increase of 2% in local currencies.  In the Americas region, revenue of $198 million rose 16%, the highest growth rate in several years.  In Europe, revenue of $117 million declined 9% in dollars and 3% in local currencies compared with last year’s second quarter.  

 

 

Selling, general and administrative expense was $159.8 million for the December quarter, compared with $153.8 million for the prior year quarter and $161.4 million for the quarter ended September 30, 2005.  SG&A expense included a reduction of $2.7 million ($1.9 million after-tax or approximately $0.01 per share), due to factoring an account receivable that the Company had provided for in the September 2005 quarter.  SG&A expense also included the effect of adopting Financial Accounting Standards Board Statement No.123(R), Share-Based Payment, which increased expense by $2.9 million ($2.1 million after-tax or approximately $0.01 per share).


The effective tax rate for the quarter was 28.5%.  This tax rate is consistent with prior guidance, but higher than the 27.0% rate in the prior year quarter, primarily due to changes in the mix of earnings by country.


Martin P. Slark, CEO and Vice-Chairman commented, “We were very pleased with our financial results for the December quarter.  The mobile phone and consumer markets were very strong and had a significant impact on our revenue growth and profit improvement.  In these markets, our growth was partially driven by our new products and design wins at the leading manufacturers.   In the Americas, we were pleased with our growth in the distribution and medical electronics markets.  Our growth in automotive was primarily due to the introduction of new products.”


Slark continued, “Our restructuring efforts are moving forward.  We were pleased with the 40 basis point sequential improvement in gross profit margin, despite a difficult raw material cost environment.  A considerable number of our management initiatives are devoted to reducing manufacturing overhead and improving margins on an individual product basis.  While a portion of the gross margin improvement was due to increased revenue, especially in our higher profit markets, we believe our internal efforts are working and contributed to this improvement.”


Cash and marketable securities were $419.8 million at December 31, 2005, compared with $423.2 million at September 30, 2005 and $412.0 million at December 31, 2004.  As described below, during the December quarter the Company spent $45.0 million to repurchase its common stock.


Orders and Backlog


Orders for the second quarter were a record $703.4 million, an increase of 15.7% over the prior year December quarter, and an increase of 1.5% sequentially from the quarter ended September 30, 2005. The Company’s order backlog on December 31, 2005 was $297.5 million, compared with $285.7 million on December 31, 2004.  The December quarter backlog increased 3.3%, from $288.0 million on September 30, 2005.


Research and Development and Capital Spending


Research and development expenditures for the December quarter were $35.7 million, compared with $34.5 million for the same period last year.  Capital expenditures for the December quarter were $66.9 million, compared with $56.9 million for the same period last year.  Depreciation expense was $52.1 million, compared with $58.3 million for the same period last fiscal year.  


Six-Month Results


Revenue for the six-months ended December 31, 2005 was $1.36 billion, an increase of 5.0% compared with the prior fiscal year.  Net income of $105.2 million, or $0.56 per share, increased 0.4% compared with last year’s net income of $104.7 million, or $0.55 per share.  Included in the current year results was a restructuring charge of $11.4 million ($8.7 million after-tax or approximately $0.05 per share), relating to the previously announced restructuring program.  For the six-months, currency translation had a minor impact on revenue, but decreased net income by $1.6 million.

 

 

March 2006 Third Quarter and Fiscal Year 2006 Outlook


The Company expects that revenue for the third fiscal quarter ending March 31, 2006, will be in a range of $690 to $710 million.  This represents an increase of 12% to 15% compared with last year’s third fiscal quarter.  The Company expects that earnings per share will be in a range of $0.28 to $0.30.  This represents an increase of 17% to 25% compared with last year’s third fiscal quarter.  This forecast includes an estimated restructuring charge of $4.5 million ($3.5 million after-tax or approximately $0.02 per share) related to the previously announced restructuring activity.  


The Company now expects that revenue for the fiscal year ending June 30, 2006 will be in a range of $2.725 to $2.800 billion, compared with previous guidance of $2.675 to $2.750 billion.  Based on these revenue expectations, earnings per share are estimated to be in a range of $1.15 to $1.19, compared with previous guidance of $1.07 to $1.12.  These earnings per share expectations include a restructuring charge of approximately $20.0 million ($15.0 million after-tax or approximately $0.08 per share).


The Company now expects that capital spending for the fiscal year ending June 30, 2006, will be in a range of $240 to $250 million, compared with previous guidance of $220 to $240 million.  This increase is primarily focused on capacity constrained products, such as micro-miniature board-to-board connectors and flash memory card sockets.  


Stock Buyback Actions


During the December quarter, the Company repurchased 1,230,000 shares of Class A Common Stock (MOLXA) and 480,000 shares of Common Stock (MOLX) at a total cost of $45 million.  The Company’s Board of Directors previously authorized the repurchase of up to an aggregate $250 million of common stock through December 31, 2006.  As of December 31, 2005, approximately $120 million was remaining under the current authorization.


Forward-Looking Statements


Statements in this release that are not historical are forward-looking and are subject to various risks and uncertainties that could cause actual results to vary materially from those stated.  Forward-looking statements are based on currently available information and include, among others, the discussion under “March 2006 Third Quarter and Fiscal Year 2006 Outlook”.  These risks and uncertainties include those associated with the operation of our business, including the risk that customer demand will decrease either temporarily or permanently, whether due to the Company's actions or the demand for the Company's products, and that the Company may not be able to respond through cost reductions in a timely and effective manner; price cutting, new product introductions and other actions by our competitors; fluctuations in the costs of raw materials that the Company is not able to pass through to customers because of existing contracts or market factors; the challenges attendant to plant closings and restructurings, including the difficulty of predicting plant closing and relocation costs, the difficulty of commencing or increasing production at existing facilities, and the reactions of customers, governmental units, employees and other groups; the challenges attendant to plant construction; and the ability to realize cost savings from restructuring activities.  Other risks and uncertainties are set forth in Molex’s documents filed with the Securities and Exchange Commission, including its Form 10-K for the year ended June 30, 2005.  Molex disclaims any obligation to revise these forward-looking statements or to provide any updates regarding information contained in this release resulting from new information, future events or otherwise.



 

 

Earnings Conference Call Information


A conference call will be held on Thursday, January 19, 2006 at 4:00 pm central.  Please dial (800) 603-3143 to participate in the conference call.  International callers please dial (706) 634-0917.  Please dial in at least five minutes prior to the start of the call and refer to conference ID 3103257.  Internet users will be able to access the web-cast, including slide materials, live and in replay in the “Investors” section of the Company’s website at www.molex.com.  A 24-hour telephone replay will be available at (800) 642-1687 or (706) 645-9291 / conference ID 3103257.


The Company’s Annual Report, as well as news releases and other supplementary financial data is available by accessing the Company’s website at www.molex.com


Investor Events


January 31, 2006 - The Molex Half Year meeting for analysts and investors will be at 9:00 am local time at the Sofitel Hotel, 45 West 44th Street, New York, NY.  Internet users will be able to access the web-cast, including slide materials, live and in replay in the “Investors” section of the Company’s website at www.molex.com.  Attending from Molex will be:  Martin Slark, Vice Chairman and CEO, Dave Johnson, CFO, and Neil Lefort, VP, Investor Relations.  If you would like to attend, please send an email to chris.gutierrez@molex.com or call (630) 527-4447.    


February 7, 2006  - The Company will present at the Thomas Weisel Partners Tech 2006 Conference in San Francisco


March 2, 2006  - The Company will present at the Prudential Mid-West Conference in Chicago


March 14, 2006 - The Company will host an open house at Molex de Mexico S.A. de C.V. in Guadalajara Mexico


March 15, 2006  - The Company will present at the Deutsche Bank Tech Conference in Miami



Molex Incorporated is a 67-year-old manufacturer of electronic components, including electrical and fiber optic interconnection products and systems, switches and integrated products, with 60 plants in 19 countries on five continents.


#   #   #


Editor’s note:  Molex is traded on the NASDAQ National Market System in the United States and on the London Stock Exchange.  The Company’s voting common stock (MOLX) is included in the S&P 500 Index.
 
 

 

 

Molex Incorporated
Condensed Consolidated Balance Sheets
(In thousands, except per share data)
 
Dec. 31,
June 30,
2005
2005
 
(Unaudited)
 
ASSETS
Current assets:
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
327,691
 
 
$
309,756
 
Marketable securities
 
 
92,158
 
 
 
187,835
 
Accounts receivable, less allowances of $23,829 and $20,293, respectively
 
 
585,676
 
 
 
539,533
 
Inventories
 
 
312,518
 
 
 
290,100
 
Other current assets
 
 
40,369
 
          
 
46,839
 
Total current assets
 
 
1,358,412
 
 
 
1,374,063
 
Property, plant and equipment, net
991,989
984,237
Goodwill
 
 
154,200
 
 
 
143,872
 
Other assets
 
 
226,295
 
 
 
225,500
 
Total assets
 
$
2,730,896
 
 
$
2,727,672
 
    
    
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
 
 
 
 
 
 
 
 
Accounts payable
 
$
256,756
 
 
$
252,370
 
Accrued expenses
 
 
153,915
 
 
 
153,464
 
Other current liabilities
 
 
61,650
 
 
 
63,670
 
Total current liabilities
 
 
472,321
 
 
 
469,504
 
Other non-current liabilities
 
 
11,590
 
 
 
10,788
 
Accrued pension and postretirement benefits
 
 
69,881
 
 
 
67,063
 
Long-term debt and obligations under capital leases
 
 
8,925
 
 
 
9,975
 
Minority interest in subsidiaries
 
 
2,369
 
 
 
2,078
 
Total liabilities
 
 
565,086
 
 
 
559,408
 
Stockholders’ equity:
 
 
 
 
 
 
Common stock
 
 
10,863
 
 
 
10,796
 
Paid-in capital
 
 
395,946
 
 
 
400,173
 
Retained earnings
 
 
2,373,071
 
 
 
2,286,826
 
Treasury stock
 
 
(669,551
)
 
 
(568,917
)
Deferred unearned compensation
 
 
--
 
 
 
(31,910
)
Accumulated other comprehensive income
 
 
55,481
 
 
 
71,296
 
Total stockholders’ equity
 
 
2,165,810
 
 
 
2,168,264
 
Total liabilities and stockholders’ equity
 
$
2,730,896
 
 
$
2,727,672
 
  
 

 

Molex Incorporated
Condensed Consolidated Statements of Income
(Unaudited)
(in thousands, except per share data)
 
 
Three Months Ended
December 31,
Six Months Ended
December 31,
2005
  
2004
  
2005
  
2004
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net revenue
 
$
697,348
 
 
$
651,818
 
 
$
1,357,163
 
 
$
1,292,048
 
Cost of sales
 
 
455,390
 
 
 
430,298
 
 
 
889,019
 
 
 
845,246
 
Gross profit
 
 
241,958
 
 
 
221,520
 
 
 
468,144
 
 
 
446,802
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Selling, general and administrative
 
 
159,753
 
 
 
153,763
 
 
 
321,170
 
 
 
309,048
 
Restructuring costs
 
 
6,517
 
 
 
--
 
 
 
11,387
 
 
 
--
 
Total operating expenses
 
 
166,270
 
 
 
153,763
 
 
 
332,557
 
 
 
309,048
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Income from operations
 
 
75,688
 
 
 
67,757
 
 
 
135,587
 
 
 
137,754
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Equity income
(3,402
)
(3,151
)
(6,511
)
(5,180
)
(Gain) loss on investments
 
 
(114
)
 
 
646
 
 
 
(114
)
 
 
1,358
 
Interest income, net
 
 
(2,659
)
 
 
(1,399
)
 
 
(4,972
)
 
 
(2,324
)
Other income, net
 
(6,175
)
 
(3,904
)
 
(11,597
)
 
(6,146
)
 
Income before income taxes and minority interest
 
81,863
 
 
71,661
 
 
147,184
 
 
143,900
 
 
Income taxes
 
 
23,331
 
 
 
19,355
 
 
 
41,947
 
 
 
38,884
 
Minority interest
 
 
29
 
 
 
60
 
 
 
63
 
 
 
286
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income
 
$
58,503
 
 
$
52,246
 
 
$
105,174
 
 
$
104,730
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Earnings per share:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic
 
$
0.31
 
 
$
0.28
 
 
$
0.56
 
 
$
0.55
 
Diluted
 
$
0.31
 
 
$
0.27
 
 
$
0.56
 
 
$
0.55
 
 
 
 
 
 
 
 
 
Dividends per share
 
$
0.0500
 
 
$
0.0375
 
 
$
0.1000
 
 
$
0.0750
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Average common shares outstanding:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic
 
186,042
 
 
188,589
 
 
186,697
 
 
188,713
 
Diluted
 
187,648
 
 
190,506
 
 
188,387
 
 
190,616
 
  
 

 

Molex Incorporated
Condensed Consolidated Statements of Cash Flows
(Unaudited)
(in thousands)
 
Six Months Ended
December 31,
2005
2004
 
 
 
 
 
 
 
 
 
Cash and cash equivalents, beginning of period
 
$
309,756
 
 
$
234,431
 
 
 
 
 
 
 
 
 
 
Operating activities:
 
 
 
 
 
 
 
 
Net income
 
 
105,174
 
 
 
104,730
 
Add non-cash items included in net income:
 
 
 
 
 
 
Depreciation and amortization
 
 
106,684
 
 
 
117,977
 
Stock-based compensation
 
 
12,695
 
 
 
7,575
 
Other non-cash charges
 
 
7,250
 
 
 
797
 
Changes in assets and liabilities, excluding effects of
 
 
 
 
 
 
foreign currency adjustments:
 
 
 
 
 
 
Accounts receivable
 
 
(52,446
)
 
 
3,227
 
Inventories
 
 
(22,476
)
 
 
(9,538
)
Accounts payable
 
 
8,265
 
 
 
(20,302
)
Other current assets and liabilities
 
 
7,267
 
 
 
(16,732
)
Other assets and liabilities
 
 
5,516
 
          
 
(4,486
)
Cash provided from operating activities
 
 
177,929
 
 
 
183,248
 
 
 
 
 
 
 
 
 
 
Investing activities:
 
 
 
 
 
 
Capital expenditures
 
 
(131,122
)
 
 
(105,343
)
Proceeds from sales of marketable securities
 
 
645,136
 
 
2,300,585
Purchases of marketable securities
(549,693
)
(2,310,474
)
Other investing activities
 
 
(17,617
)
 
 
14,373
Cash used for investing activities
 
(53,296
)
 
(100,859
)
    
Financing activities:
 
 
 
 
 
 
 
 
Net decrease in debt
 
 
(2,519
)
 
 
(392
)
Cash dividends paid
 
 
(16,351
)
 
 
(11,799
)
Principal payments on capital leases
 
 
(1,401
)
 
 
(1,713
)
Exercise of stock options
 
 
9,185
 
 
5,002
Purchase of treasury stock
 
 
(95,114
)
 
 
(23,615
)
Reissuance of treasury stock
 
 
--
 
 
438
Cash used for financing activities
 
 
(106,200
)
 
 
(32,079
)
 
 
 
 
 
 
 
 
 
Effect of exchange rate changes on cash
 
 
(498
)
 
 
12,903
 
Net increase in cash and cash equivalents
 
 
17,935
 
 
63,213
Cash and cash equivalents, end of period
 
$
327,691
 
 
$
297,644